Free Trial

Mereo BioPharma Group (MREO) SEC Filings & 10K Form

Mereo BioPharma Group logo
$1.71 -0.04 (-2.29%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$1.73 +0.02 (+1.17%)
As of 08/29/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mereo BioPharma Group SEC Filings

DateFilerForm TypeView
08/14/2025
10:15 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
08/12/2025
6:55 AM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2025
6:40 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
5:49 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
6:51 PM
Mereo BioPharma Group (Subject)
Northpond Ventures, LP (Filed by)
Form SCHEDULE 13G
05/15/2025
9:46 AM
Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
Form SCHEDULE 13G/A
05/13/2025
6:48 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
6:57 AM
Mereo BioPharma Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
8:01 AM
Adage Capital Management, L.P. (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
04/08/2025
5:45 AM
Mereo BioPharma Group (Filer)
Form ARS
04/08/2025
5:41 AM
Mereo BioPharma Group (Filer)
Form DEF 14A
04/04/2025
11:39 AM
Frazier Life Sciences Public Fund, L.P. (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G
03/26/2025
6:44 AM
Mereo BioPharma Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2025
6:38 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:34 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
02/06/2025
3:30 PM
Jacquet Pierre (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Jenkins Annalisa (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
WYZGA MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
Shames Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Ekblom Anders (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Bender Jeremy (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:30 PM
Mereo BioPharma Group (Issuer)
Yoskowitz Marc J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:07 PM
Mereo BioPharma Group (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/13/2025
5:32 AM
Mereo BioPharma Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
10:37 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SCHEDULE 13G/A
11/14/2024
10:44 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
Form SC 13G/A
11/12/2024
3:49 PM
Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
09/16/2024
7:46 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:47 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:48 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
7:50 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:47 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:49 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:50 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:57 PM
Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:05 PM
Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
09/12/2024
3:05 PM
Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:05 PM
Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MREO) was last updated on 8/31/2025 by MarketBeat.com Staff
From Our Partners